Illumina

Senior Sequencing Sales Specialist - LA/OC/HI

United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Life SciencesIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate a minimum of 7 years of experience in sales, with a preference for those specializing in sequencing or molecular biology products. Strong knowledge of Illumina’s sequencing and multiomic product portfolios is essential, along with demonstrated ability to build and maintain customer relationships.

Responsibilities

The Senior Sequencing Sales Specialist will collaborate with various teams to achieve regional sales objectives, actively monitor market and competitor activities, and regularly meet with customers to present technical seminars on Illumina Sequencing product lines and sequencing applications. They will also develop customized territory plans, ensure the sales team is trained on relevant information, represent the company professionally, and assist with marketing activities as needed.

Skills

sequencing technologies
multiomic technologies
scientific communication
customer relationship management
training and mentoring
market analysis
technical seminars
industry trends
product knowledge

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI